Skip to main content
. 2024 Jan 5;24:37. doi: 10.1186/s12885-023-11772-8

Table 8.

Adverse events after GKRS

Adverse reactions Number of LGG patients (%) Average duration Number of HGG patients (%) Average duration
None 28(87.5) 46(82.1)
Headache (grade I) 2(6.3) 2d 4(7.1) 3d
Headache (grade II) 1(3.1) 3d 2(3.6) 5d
Dizziness (grade I) 1(3.1) 1d 3(5.4) 2d
Nausea and vomiting 1(3.1) 2d 2(3.6) 2d
Fatigue (grade I) 0(0) 2(3.6) 3d
Somnolence (grade I) 0(0) 1(1.8) 3d
Excessive fatigue 0(0)